Amgen and Duke Clinical Research Institute initiated first large-scale registry to evaluate real-world lipid management
On Nov. 15, 2019, Amgen in collaboration with the Duke Clinical Research Institute (DCRI) announced plans to initiate…
Researchers at UCSD School of Medicine successfully applied phage therapy in mice to treat alcohol-related liver disease
On Nov. 13, 2019, researchers at University of California San Diego (UCSD) School of Medicine announced that they…
Merck acquired San Diego’s Calporta for up to $576 million
On Nov. 12, 2019, Calporta Therapeutics, one of eight San Diego biotech companies Avalon Ventures created with GlaxoSmithKline,…
Biotechnology | CDC | Diagnostics | Genomics | HIV | Therapeutics
Abbott announced discovery of a new strain of HIV
On Nov. 6, 2019, Abbott announced that a team of its scientists identified a new subtype of the…
Karmanos Cancer Institute established the McLaren Proton Therapy Center
On Oct. 30, 2019, the Barbara Ann Karmanos Cancer Institute established the McLaren Proton Therapy Center, one of…
Researchers at UGA’s Center for the Ecology of Infectious Diseases received a $16 million grant to study tropical diseases
On Oct. 30, 2019, researchers at the University of Georgia’s Center for the Ecology of Infectious Diseases received…
Helmsley Foundation awarded $13 million in grants for the Gut Cell Atlas
On Oct. 27, 2019, the Leona M. and Harry B. Helmsley Charitable Trust announced it had awarded $13…
Sanford Burnham Prebys scientists developed a machine-learning algorithm that gleans information from microscope images
On Oct. 22, 2019, scientists at Sanford Burnham Prebys announced they had developed a machine-learning algorithm that gleans…
Lundbeck acquired Alder BioPharmaceuticals for $1.95 billion
On Oct. 22, 2019, Lundbeck, located in Valby, Denmark, announced it had completed its acquisition of Bothell, Washington-based…
Genentech announced FDA approval of antiviral drug Xofluza (Baloxavir Marboxil)
On Oct. 17, 2019, Genentech announced the U.S. Food and Drug Administration (FDA) had approved Xofluza (Baloxavir Marboxil),…
Penn Medicine received $22 million from NIH HEAL Initiative to combat the national opioid crisis
On Oct. 4, 2019, Penn Medicine announced they had received $22 Million from National Institutes of Health’s (NIH)…
New York State experienced measles outbreak
On Oct. 3, 2019, the New York State Department of Health announced that more than 42 days –…
New York State declared measles free
On Oct. 3, 2019, the New York State Department of Health announced that more than 42 days –…
The Masonic Cancer Center and the University of Minnesota opened a first-in-human clinical trial for treatment of advanced solid tumors
On Oct. 2, 2019, the Masonic Cancer Center and the University of Minnesota (UM) opened a new first-in-human…
Emory Selected to lead international drug discovery center for Alzheimer’s
On Oct 1, 2019, the National Institute on Aging (NIA) announced it had awarded approximately $37 million over…
NIH grant awarded to Georgia Tech researchers to develop mRNA-based drug to correct hematopoietic stem cells
On Oct. 1, 2019, the National Institutes of Health (NIH) awarded a $3.5 million grant to Georgia Institute…
The NIH awarded up to $130 million over seven years for UGA to develop universal flu vaccine
On Sept. 30, 2019, the University of Georgia (UGA) announced it had signed a contract with the National…
Seattle Children’s received $30 million NIH funding to establish centers for TB vaccine development
On Sept. 26, 2019, Seattle Children’s announced it was one of three recipients of $30 million in first-year-funding…
Biotechnology | Diagnostics | Disease | NIH | Non-Profit Research | Oncology | Radiology | Therapeutics
Karmanos, Wayne State received $3.1 million NIH grant to improve quality of life for African American cancer survivors
On Sept. 24, 2019 Karmanos, Wayne State announced it had received a $3.1 million National Institutes of Health…
Karmanos Cancer Institute and the University of Michigan Rogel Cancer Center received a $9.2 million grant from the National Cancer Institute
On Sept. 23, 2019, the Barbara Ann Karmanos Cancer Institute and the University of Michigan Rogel Cancer Center…
Pascal Biosciences discovered cannabinoids activate the major histocompatibility complex to aid cancer treatment
On Sept. 23, 2019, Pascal Biosciences identified specific cannabinoids that enhance the immunogenicity of tumor cells, rendering them…
UCLA clinical trial resulted in a brain implant to help restore visual perception to the blind
On Sept. 18, 2019, researchers from the University of California, Los Angeles (UCLA) announced developing a device geared…
UPenn completed exclusive R&D alliance with Novartis
On Sept. 12, 2019, UPenn completed its exclusive, 7-year research and development alliance with Novartis, that spawned the…
deCODE in Iceland agreed to sequence half of UK Biobank participants, largest ever undertaken
On Sept. 11, 2019, deCODE genetics in Iceland announced an agreement with a consortium of government, charity, researchers…
Scientists at Sanford Burnham Prebys have identified the long-sought structure of an essential blood protein: Vitronectin
On Sept. 11, 2019, scientists at Sanford Burnham Prebys announced they had identified the long-sought structure of an…
IRBM signed agreement with MD Anderson Cancer Center to generate novel immune-checkpoint monoclonal antibodies
On Sept. 9, 2019, IRBM announced the signing of a service and development agreement with The University of…
MouseLight Project mapped 1,000 neurons in the mouse brain
On Sept. 5, 2019, researchers at the Howard Hughes Medical Instituteﾒs Janelia Research Campus announced that they had…
Penn researcher Virginia MY Lee, PhD, received $3 million Breakthrough Prize
On Sept. 5, 2019, Penn Professor Virginia M.Y. Lee, PhD received the Breakthrough Prize in Life Sciences, in…
University of Alberta researchers discovered the protein PEX3 in the cells of deadly parasite trypanosome
On Aug. 26, 2019, University of Alberta researcher Rick Rachubinski and colleagues announced they had discovered the protein…
Amgen acquired worldwide rights to psoriasis drug Otezla (apremilast) For $13.4 Billion
On Aug. 26, 2019, Amgen acquired worldwide rights to Otezlaﾮ (apremilast), the only oral, non-biologic treatment for psoriasis…